Consensual Donation and Research Integrity Act of 2025
- Sponsor
- Rep. Bilirakis, Gus M. [R-FL-12]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Apr 2, 2025
Bottom line
The bill creates a federal oversight system for the non-transplant human body donation industry to enhance ethical practices, transparency, and donor protections.
What it actually does
This bill establishes a new federal regulatory framework under the Public Health Service Act for entities that acquire and sell for profit whole human bodies or body parts for education, research, or the advancement of medical, dental, or mortuary science, excluding use in human transplantation. It mandates federal registration, detailed record-keeping, standardized labeling and packaging, strict privacy protections for donor information, and ensures proper final disposition of remains. Violations are subject to fines and potential revocation of registration.
Proponents argue
Supporters argue this bill addresses a critical regulatory gap in the non-transplant human body donation industry, protecting donors and their families from exploitation and ensuring respectful handling and disposition of human remains. They contend it will bring much-needed transparency and accountability to a currently under-regulated sector, fostering public trust in scientific and medical research.
Opponents contend
Potential opponents might argue that the bill imposes excessive regulatory burdens on legitimate research and educational institutions, potentially increasing costs and hindering scientific advancement. They might also contend that existing state laws are sufficient or that federal intervention constitutes an overreach into an area traditionally managed at the state level.
The bill is concise enough for an informed reader to understand its core provisions within a reasonable timeframe, though the regulatory details it delegates to HHS will be crucial.
Section 2, new Section 373A(a)
Mandatory Federal Registration for For-Profit Body Part Acquirers
This provision requires any person who acquires human bodies and sells for profit a whole human body or human body part in or affecting interstate commerce (for non-transplantation purposes) to register with the Secretary of Health and Human Services. Applicants must provide detailed business information, premises descriptions, service types, and assurances of compliance with inspection, record-keeping, labeling, packaging, and information disclosure rules. Fees will be established to cover the costs of implementation and enforcement.
Supporters argue
Supporters argue this registration is essential to identify and track entities operating in this industry, providing a foundational layer of accountability where none currently exists at the federal level, thereby enhancing transparency and preventing exploitation.
Critics contend
Some entities might argue that this creates an unnecessary bureaucratic hurdle, especially for smaller organizations, potentially increasing operational costs that could be passed on or hindering the availability of materials for research.
Tradeoffs
This provision balances the need for federal oversight and consumer protection against potential administrative burdens and increased costs for businesses operating in the body donation sector.
Section 2, new Section 373A(a)(2)
Exemptions from Registration Requirement
The bill explicitly exempts several categories of entities from the federal registration requirement. These include the Organ Procurement and Transplantation Network (OPTN) and its members, funeral service professionals (regarding preparation, transportation, and final disposition), and non-profit schools of medicine, dentistry, mortuary science, and research/training organizations that do not sell for profit a whole body or body part. This narrows the bill's focus to for-profit sales in the non-transplant sector.
Section 2, new Section 373A(c)
Detailed Record-Keeping Requirements
Registrants are mandated to maintain comprehensive records for each human body or body part acquired. These records must include documentation of the donor's knowing consent for non-transplant use, information on the final disposition, the date and time of donation, the names of all prior possessors (e.g., funeral homes, hospitals), the donor's full name and address, a description of the parts, the donor's medical history (including autopsy reports if available), and documentation of the registrant's use and subsequent transfers of the remains.
Section 2, new Section 373A(d)
Standardized Labeling and Packaging Requirements
The bill requires registrants to ensure all human bodies and body parts in their possession or transferred by them are labeled and packaged according to federal regulations, maintaining a proper chain of custody. Labels, affixed beneath outer packaging, must include the donor's proper name, a description of contents, transferor information, tissue types, cause of death (if known), serological test results, records of radioactive materials/implants, known infectious disease agents, a statement on universal precautions, and the explicit phrase 'not for transplantation.' Packaging must prevent contamination, safety hazards, leakage, and ensure integrity.
Section 2, new Section 373A(f)
Mandate for Respectful Final Disposition of Remains
This provision requires registrants to ensure the proper disposition of human bodies or body parts in accordance with applicable federal and state law. This obligation can be fulfilled by returning the remains to a relative or personal representative of the donor, carrying out disposition according to the written instructions of those with the right to control disposition, or by contracting with another person (upon transfer of the remains) to assume this disposition obligation. This ensures that the final resting place of donated remains is handled respectfully and according to wishes.
Section 2, new Section 373A(g)
Enforcement and Penalties for Violations
The bill establishes penalties for any person who violates its requirements, including fines in accordance with Title 18, United States Code. Additionally, the Secretary of HHS is granted authority to suspend or revoke the registration of any registrant found to be in violation. The provision specifically states that altering or falsifying any information in a required label is a violation, providing a clear basis for enforcement actions related to transparency and accuracy.
The amendments made by this Act, establishing the new federal regulatory framework, will apply to any acquisition or transfer of a human body or human body parts that occurs after the date that is 2 years after the date of the enactment of this Act.
Section 2(b)
Why it matters:This is standard legislative practice for setting an effective date or a transition period, often placed at the end of an amending section rather than within the new statutory language itself.
Case for: This two-year grace period provides affected entities with sufficient time to understand the new federal regulations, establish compliance protocols, update their record-keeping and labeling systems, and obtain the necessary registration, allowing for an orderly transition without immediate disruption to legitimate operations.
Case against: Critics might argue that a two-year delay is too long for an industry identified as needing urgent oversight, potentially leaving donors and families vulnerable to continued unethical practices for an extended period before federal protections take effect.
Estimated impact: Delays the effective date of all new federal regulations, including registration, record-keeping, labeling, and disposition mandates, by two years from the bill's enactment date.